Trinity Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRIB and other ETFs, options, and stocks.

About TRIB

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World-Ireland geographical segments. 

CEO
John Gillard
CEOJohn Gillard
Employees
287
Employees287
Headquarters
Bray, Wicklow
HeadquartersBray, Wicklow
Founded
1992
Founded1992
Employees
287
Employees287

TRIB Key Statistics

Market cap
4.99M
Market cap4.99M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
Dividend yield
Average volume
14.40K
Average volume14.40K
High today
$7.99
High today$7.99
Low today
$6.85
Low today$6.85
Open price
$7.99
Open price$7.99
Volume
12.04K
Volume12.04K
52 Week high
$52.50
52 Week high$52.50
52 Week low
$6.85
52 Week low$6.85

TRIB News

TipRanks 4d
Trinity Biotech’s Trinovium Unit Signs AI Data Center Cooling Pilot Deal with Red Team Investments - TipRanks

...

Trinity Biotech’s Trinovium Unit Signs AI Data Center Cooling Pilot Deal with Red Team Investments - TipRanks
TipRanks 5d
Trinity Biotech Files 2025 Annual Report and AGM Materials with SEC

Trinity Biotech ( (TRIB) ) has shared an announcement. On September 8, 2026, Trinity Biotech filed a Form 6-K with the U.S. Securities and Exchange Commission,...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.